Pharmacological use of l-carnitine in uremic anemia: Has its full potential been exploited?

Pharmacological Research

Volumn 63, Issue 3, 2011, Pages 157-164

  Bonomini, Mario ^a   Zammit, Victor ^b   Pusey, Charles D ^c   De Vecchi, Amedeo ^d   Arduini, Arduino ^e  

^a UNIVERSITY OF CHIETI   (Italy)

^b UNIVERSITY OF WARWICK   (United Kingdom)

^c HAMMERSMITH HOSPITAL   (United Kingdom)

^d FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^e Department of Research and Development ^*  (Switzerland)

Author keywords

Anemia; Drug metabolism; Erythropoietin; Hemodialysis; Kidney failure; l Carnitine

Indexed keywords

CARNITINE; CARNITINE PALMITOYLTRANSFERASE; CASPASE 3; CERAMIDE; ERYTHROPOIETIN; FAS ANTIGEN; PALMITOYLCARNITINE; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLSERINE; PLACEBO; TRANSCRIPTION FACTOR GATA 1;

ANEMIA; APOPTOSIS; BIOPHYSICS; CELL DIFFERENTIATION; CELL FUNCTION; CELL INTERACTION; CELL METABOLISM; DOSE RESPONSE; DRUG BINDING; DRUG MECHANISM; DRUG RESISTANCE; ENZYME ACTIVATION; ENZYME INHIBITION; ERYTHROCYTE; ERYTHROCYTE DEFORMABILITY; ERYTHROCYTE LIFESPAN; ERYTHROCYTE MEMBRANE; ERYTHROCYTE METABOLISM; ERYTHROPOIESIS; FATTY ACID OXIDATION; FATTY ACID TRANSPORT; HEMODIALYSIS; HEMOLYSIS; HUMAN; LIPOGENESIS; METABOLIC PARAMETERS; MITOCHONDRIAL MEMBRANE; NONHUMAN; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; TREATMENT DURATION; TREATMENT OUTCOME; TURBIDITY; UREMIA; VISCOELASTICITY; VITAMIN SUPPLEMENTATION;

EID: 79751533090     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2010.11.006     Document Type: Article

References (102)

1. H.W. Radtke, A. Klaussner, P.M. Erbes, E.H. Scheuermann, W. Schoeppe, and K.M. Koch Serum erythropoietin concentration in CRF: relationship to degree of anemia and excretory renal function Blood 54 1979 877 884 (Pubitemid 10247560)
2. J.W. Eschbach, M.R. Downing, J.C. Egrie, J.K. Browne, and J.W. Adamson USA multicenter clinical trial with recombinant human erythropoietin Contrib Nephrol 76 1989 160 165
3. C.G. Winearls, D.O. Oliver, M.J. Pippard, C. Reid, M.R. Downing, and P.M. Cotes Effect of human erythropoietin derived from recombinant DNA on the anaemia of patients maintained by chronic haemodialysis Lancet 2 1986 1175 1178
4. A.J. Collins Influence of target haemoglobin in dialysis patients on morbidity and mortality Kidney Int 80 Suppl. 2000 2000 44 48
5. F. Moreno, D. Sanz-Guajardo, J.M. Lopez-Gomez, R. Jofre, and F. Valderrabano Increasing the hematocrit has a beneficial effect on quality of life and is safe in selected hemodialysis patients. Spanish Cooperative Renal Patients Quality of Life Study Group of the Spanish Society of Nephrology J Am Soc Nephrol 11 2001 335 342 (Pubitemid 30064857)
6. KDOQI clinical practice guideline and clinical practice recommendations for anemia in chronic kidney disease, 2007 update of haemoglobin target. Am J Kidney Dis 2007;50:471-530.
7. F. Locatelli, A. Covic, K.U. Eckardt, A. Wiecek, and R. Vanholder Anaemia management in patients with chronic kidney disease: a position statement by the Anaemia Working Group of European Renal Best Practice (ERBP) Nephrol Dial Transplant 24 2009 348 354
8. United States Renal Data System United States Renal Data System 2006 annual data report Atlas of chronic kidney disease & end-stage renal disease in the United States Am J Kidney Dis 49 2007 1 296
9. K. Kalantar-Zadeh, and G.R. Aronoff Hemoglobin variability in anemia of chronic kidney disease J Am Soc Nephrol 20 2009 479 487
10. T.B. Drueke, F. Locatelli, N. Clyne, K.U. Eckardt, I.C. Macdougall, and D. Tsakiris CREATE investigators: normalization of haemoglobin level in patients with chronic kidney disease and anemia N Engl J Med 355 2006 2071 2084 (Pubitemid 44749316)
11. A.K. Singh, L. Szczech, K.L. Tang, H. Barnhart, S. Sapp, and M. Wolfson Correction of anemia with epoetin alfa in chronic kidney disease N Engl J Med 355 2006 2085 2098 (Pubitemid 44749317)
12. M. Pfeffer, E. Burdmann, C-Y. Chen, M.E. Cooper, D. de Zeeuw, and K.-U. Eckardt For the TREAT investigators. A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease N Engl J Med 361 2009 1 14
13. C.J. Diskin, T.J. Stokes, L.M. Dansby, L. Radcliff, and T.B. Carter Beyond anemia: the clinical impact of the physiologic effects of erythropoietin Semin Dial 21 2008 447 454
14. M.H. Rosner, and W.K. Bolton The mortality risk associated with higher hemoglobin: is the therapy to blame? Kidney Int 74 2008 695 697
15. P. Marsden Treatment of anemia in chronic kidney disease-Strategies based on evidence N Engl J Med 361 2009 1 14
16. R.M. Kalicki, and D.E. Uehlinger Red cell survival in relation to changes in the hematocrit: more important than you think Blood Purif 26 2008 355 360
17. J. Ly, R. Marticorena, and S. Donnelly Red blood cell survival in chronic renal failure Am J Kidney Dis 44 2004 715 719 (Pubitemid 39237616)
18. M.L. Ellsworth, C.G. Ellis, D. Goldman, A.H. Stephenson, H.H. Dietrich, and R.S. Sprague Erythrocytes: oxygen sensors modulators of vascular tone Physiology (Bethesda) 24 2009 107 116
19. A. Steiber, J. Kerner, and C.L. Hoppel Carnitine: a nutritional, biosynthetic, and functional perspective Mol Aspects Med 25 2005 455 473
20. R.R. Ramsay, and A. Arduini The carnitine acyltransferases and their role in modulating acyl-CoA pools Arch Biochem Biophys 302 1993 307 314 (Pubitemid 23212675)
21. V.A. Zammit Carnitine acyltransferases: functional significance of subcellular distribution and membrane topology Prog Lipid Res 38 1999 199 224 (Pubitemid 29328966)
22. S. Ahmad l-Carnitine in dialysis patients Semin Dial 14 2001 209 217 (Pubitemid 33720854)
23. T.I. Steinman l-Carnitine supplementation in dialysis patients: does the evidence justify its use? Semin Dial 18 2005 1 2 (Pubitemid 40348267)
24. B. Schreiber Common misconceptions about levocarnitine and dialysis Semin Dial 18 2005 349 354
25. G.J. Doherty, and H.T. McMahon Mediation, modulation, and consequences of membrane-cytoskeleton interactions Annu Rev Biophys 37 2008 65 95
26. E.A. Evans, and R.M. Hochmuth Membrane visco elasticity Biophys J 16 1976 1 11
27. E.A. Evans, R. Waugh, and L. Melnik Elastic area compressibility modulus of red cells membrane Biophys J 16 1976 585 595
28. G.R. Cokelet, and H.J. Meiselman Rheological comparison of haemoglobin solutions and erythrocyte suspensions Science 162 1968 275 277
29. J.L. Paul, N.D. Sall, T. Soni, J.L. Poignet, A. Lindenbaum, and N.K. Man Lipid peroxidation abnormalities in hemodialysed patients Nephron 64 1993 106 109 (Pubitemid 23117178)
30. D. Paskalev, P. Tchankova, T. Jankova, M. Steiner, and D. Nenov Alteration in red blood cell sodium and potassium concentration in uremic patients on maintenance hemodialysis undergoing treatment with recombinant erythropoietin Am J Nephrol 14 1994 246 248 (Pubitemid 24257971)
31. M.C. Delmas-Beauvieux, C. Combe, E. Peuchant, M.A. Carbonneau, L. Dubourg, and V. de Precigout Evaluation of red blood cell lipoperoxidation in hemodialysed patients during erythropoietin therapy supplemented or not with iron Nephron 69 1995 404 410
32. D. Nenov, D. Paskalev, T. Yankova, and P. Tchankova Lipid peroxidation and vitamin E in red blood cells and plasma in hemodialysis patients under rhEPO treatment Artif Organs 19 1995 436 439
33. M. Viljoen, A.A. de Oliveira, and F.J. Milne Physical properties of the red blood cells in chronic renal failure Nephron 59 1991 271 278
34. P. Zachee, A. Ferrant, R. Daelemans, L. Coolen, W. Goossens, and R.L. Lins Oxidative injury to erythrocytes, cell rigidity and splenic hemolysis in hemodialyzed patients before and during erythropoietin treatment Nephron 65 1993 288 293 (Pubitemid 23268041)
35. T. Linde, B. Sandhagen, B. Wikstrom, and B.G. Danielson The required dose of erythropoietin during renal anaemia treatment is related to the degree of impairment in erythrocyte deformability Nephrol Dial Transplant 12 1997 2375 2379 (Pubitemid 27474621)
36. C.D. Brown, Z.H. Zhao, L.L. Thomas, R. deGroof, and E.A. Friedman Effects of erythropoietin and aminoguanidine on red blood cell deformability in diabetic azotemic and uremic patients Am J Kidney Dis 38 2001 1414 1420 (Pubitemid 34193136)
37. D.J. Fisher, N.J. Torrence, R.J. Sprung, and D.M. Spence Dtermination of erythrocyte deformability and its correlation to cellular ATP release using microbore tubing with diameters that approximate resistance vessels in vivo Analyst 128 2003 1163 1168 (Pubitemid 37159436)
38. J. Wan, W.D. Ristenpart, and H.A. Stone Dynamics of shear-induced ATP release from red blood cells Proc Natl Acad Sci USA 105 2009 16432 16437
39. S. Nikolaos, A. George, T. Telemachos, S. Maria, M. Yannis, and M. Konstantinos Effect of l-carnitine supplementation on red blood cells deformability in hemodialysis patients Renal Fail 22 2000 73 80 (Pubitemid 30130938)
40. E. Berard, D. Barillon, A. Iordache, J. Bayle, and E. Cassuto-Viguier Low dose of l-carnitine impairs membrane fragility of erythrocytes in hemodialysis patients Nephron 68 1994 145 (Pubitemid 24251207)
41. M. Matsumura, S. Hatakeyama, I. Koni, H. Mabuchi, and H. Muramoto Correlation between serum carnitine levels and erythrocyte osmotic fragility in hemodialysis patients Nephron 72 1996 574 578 (Pubitemid 26098255)
42. D. Vlassopoulos, D.K. Hadjiyannakos, A.G. Anogiatis, A.E. Evageliou, A.V. Santikou, and C.V. Noussias Carnitine action on red blood cell osmotic resistance in hemodialysis patients J Nephrol 15 2002 68 73 (Pubitemid 34240100)
43. J. Kletzmayr, G. Mayer, E. Legenstein, G. Heinz-Peer, T. Leitha, and W.H. Horl Anemia and carnitine supplementation in hemodialyzed patients Kidney Int 69 1999 S93 S106
44. S. Reuter, R. Fauell, E. Ranieri, and A. Evans Endogenous plasma carnitine pool composition and response to erythropoietin treatment in chronic haemodialysis patients Nephrol Dial Transplant 24 2009 990 996
45. A. Kobayashi, H. Watanabe, S. Fujisawa, T. Yamamoto, and N. Yamazaki Effects of l-carnitine and palmitoylcarnitine on membrane fluidity of human erythrocytes Biochim Biophys Acta 986 1989 83 88 (Pubitemid 19281626)
46. A. Arduini, N. Gorbunov, E. Arrigoni-Martelli, S. Dottori, F. Molajoni, and F. Russo Effects of l-carnitine and its acetate and propionate esters on the molecular dynamics of human erythrocyte membrane Biochim Biophys Acta 1146 1993 229 235 (Pubitemid 23084767)
47. A. Arduini, M. Rossi, G. Mancinelli, M. Belfiglio, R. Scurti, and G. Radatti Effect of l-carnitine and acetyl-l-carnitine on the human erythrocyte membrane stability and deformability Life Sci 47 1990 2395 2400
48. D.A. Butterfield, and A. Rangachari Acetylcarnitine increases membrane cytoskeletal protein-protein interactions Life Sci 52 1993 297 303
49. J. McKenney, C.R. Valeri, N. Mohandas, N. Fortier, A. Giorgio, and L.M. Snyder Decreased in vivo survival of hydrogen peroxide-damaged baboon red blood cells Blood 76 1990 206 211 (Pubitemid 20220812)
50. L.C. Wolfe, A.M. Byrne, and S.E. Lux Molecular defect in the membrane skeleton of blood bank-stored red cells. Abnormal spectrin-protein 4.1-actin complex formation J Clin Invest 78 1986 1681 1686 (Pubitemid 17219533)
51. A. Arduini, S. Holme, J.D. Sweeney, S. Dottori, A.F. Sciarroni, and M. Calvani Addition of l-carnitine to additive solution-suspended red cells stored at 4 degrees C reduces in vitro hemolysis and improves in vivo viability Transfusion 37 1997 166 174 (Pubitemid 27091902)
52. A. Arduini, V. Tyurin, Y. Tyuruna, E. Arrigoni-Martelli, F. Molajoni, and S. Dottori Acyl-trafficking in membrane phospholipid fatty acid turnover: the transfer of fatty acid from the acyl-l-carnitine pool to membrane phospholipids in intact human erythrocytes Biochem Biophys Res Commun 187 1992 353 358
53. A. Arduini Carnitine its acyl esters as secondary antioxidants? Am Heart J 123 1992 1726 1727
54. B. de los Reyes, J.A. Navarro, R. Perez-Garcia, A. Liras, Y. Campos, and B. Bornstein Effects of l-carnitine on erythrocyte acyl-CoA, free CoA, and glycerophospholipid acyltransferase in uremia Am J Clin Nutr 67 1998 386 390 (Pubitemid 28110457)
55. N. Andrieu-Abadie, J.P. Jaffrezou, S. Hatem, G. Laurent, T. Levade, and J.J. Mercadier l-Carnitine prevents doxorubicin-induced apoptosis of cardiac myocytes: role of inhibition of ceramide generation FASEB J 13 1999 1501 1510 (Pubitemid 29411782)
56. M.C. Mutomba, H. Yuan, M. Konyavko, S. Adachi, C.B. Yokoama, and V. Esser Regulation of the activity of caspases by l-carnitine and palmitoylcarnitine FEBS Lett 478 2000 19 25 (Pubitemid 30462251)
57. F. Lang, E. Gulbins, H. Lerche, S.M. Huber, D.S. Kempe, and M. Foller A window to systemic disease Cell Physiol Biochem 22 2008 373 380
58. D. Mandal, A. Mazumder, P. Das, M. Kundu, and J. Basu Fas-, caspase 8-, and caspase 3-dependent signaling regulates the activity of the aminophospholipid translocase and phosphatidylserine externalization in human erythrocytes J Biol Chem 280 2005 39460 39467 (Pubitemid 41713903)
59. R.F.A. Zwaal, and A.J. Schroit Pathophysiologic implications of membrane phospholipid asymmetry in blood cells Blood 89 1997 1121 1132 (Pubitemid 27079974)
60. M. Bonomini, V. Sirolli, N. Settefrati, S. Dottori, L. Di Liberato, and A. Arduini Increased erythrocyte phosphatidylserine exposure in chronic renal failure J Am Soc Nephrol 10 1999 1982 1990 (Pubitemid 29402520)
61. M. Bonomini, V. Sirolli, M. Reale, and A. Arduini Involvement of phosphatidylserine exposure in the recognition and phagocytosis of uremic erythrocytes Am J Kidney Dis 37 2001 807 814 (Pubitemid 32268042)
62. A. Arduini, M. Bonomini, E.J. Clutterbuck, M.A. Laffan, and C.D. Pusey Effects of l-carnitine administration on erythrocyte survival in haemodialysis patients Nephrol Dial Transplant 21 2006 2671 2672 (Pubitemid 44644559)
63. M. Matsumura, S. Hatakeyama, I. Koni, and H. Mabuchi Effect of l-carnitine and palmitoyl-l-carnitine on erythroid colony formation in fetal mouse liver cell culture Am J Nephrol 18 1998 355 358 (Pubitemid 28442095)
64. Y. Kitamura, K. Satoh, T. Satoh, M. Takita, and A. Matsuura Effect of l-carnitine on erythroid colony formation in mouse bone marrow cells Nephrol Dial Transplant 20 2005 981 984 (Pubitemid 40704037)
65. R. De Maria, A. Zeuner, A. Eramo, C. Domenichelli, D. Bonci, and F. Grignani Negative regulation of erythropoiesis by caspase-mediated cleavage of GATA-1 Nature 401 1999 489 493
66. M. Bonomini, V. Sirolli, S. Dottori, L. Amoroso, L. Di Liberato, and A. Arduini l-Carnitine inhibits a subset of platelet activation responses in chronic uraemia Nephrol Dial Transplant 22 2007 2623 2639
67. L. Cal, P. Davis, E. Pagnin, L. Battipaglia, A. Naso, and A. Piccoli Carnitine-mediated improved response to erythropoietin involves induction of haem oxygenase-1: studies in humans and in an animal model Nephrol Dial Transplant 23 2008 890 895 (Pubitemid 351767567)
68. M.D. Maines The heme oxygenase system: a regulator of second messenger gases Annu Rev Pharmacol Toxicol 37 1997 517 554 (Pubitemid 27238886)
69. G. Fortin, K. Yurchenko, C. Collette, M. Rubio, A.C. Villani, and A. Bitton A diet component and organic cation transporter OCTN ligand, displays immunosuppressive properties and abrogates intestinal inflammation Clin Exp Immunol 156 2009 161 171
70. T. Drueke Hyporesponsiveness to human recombinant erythropoietin Nephrol Dial Transplant 16 Suppl. 7 2001 25 28
71. I.C. Macdougall, and A.C. Cooper Hyporesponsiveness to erythropoietic therapy due to chronic inflammation Eur J Clin Invest 35 Suppl. 3 2005 32 35 (Pubitemid 41783602)
72. V. Savica, D. Santoro, G. Mazzaglia, F. Ciolino, P. Monardo, and M. Calvani l-Carnitine infusions may suppress C-reactive protein and improve nutritional status in maintenance hemodialysis patients J Ren Nutr 15 2005 225 230
73. M. Duranay, H. Akay, F.M. Yilmaz, M. Senes, N. Tekeli, and D. Yücel Effects of l-carnitine infusions on inflammatory and nutritional markers in haemodialysis patients Nephrol Dial Transplant 21 2006 3211 3214 (Pubitemid 44567096)
74. G. Pertosa, G. Grandaliano, S. Simone, M. Soccio, and F.P. Schena Inflammation and carnitine in hemodialysis patients J Ren Nutr 15 2005 8 12 (Pubitemid 40093675)
75. J. Hurot, M. Cucherat, M. Haugh, and D. Fouque Effects of l-carnitine supplementation in maintenance hemodialysis patients: a systematic review J Am Soc Nephrol 13 2002 708 714 (Pubitemid 34183936)
76. S. Hedayati Dialysis-related carnitine disorder Semin Dial 19 2006 323 328 (Pubitemid 44091708)
77. S. Reuter, R. Faull, and A. Evans l-Carnitine supplementation in the dialysis population: are Australian patients missing it? Nephrology 13 2008 3 16
78. A. Albertazzi, P. Cappelli, B. Di Paolo, P. Pola, P. Tondi, and O. Vaccario Endocrine-metabolic effects of l-carnitine in patients on regular dialysis treatment Proc Eur Dial Transplant Assoc 19 1983 302 307
79. G. Trovato, V. Ginardi, V. Di Marco, A.E. Dell'Aira, and M. Corsi Long-term l-carnitine treatment of chronic anaemia of patients with end-stage renal failure Clin Ther Res 31 1982 1042 1049
80. G. Vacha, G. Giorcelli, N. Siliprandi, and M. Corsi Favorable effects of l-carnitine treatment on hypertriglyceridemia in hemodialysis patients: decisive role of low levels of high-density lipoprotein-cholesterol Am J Clin Nutr 38 1983 532 540 (Pubitemid 13010198)
81. G. Bellinghieri, V. Savica, A. Mallamace, C. Di Stefano, F. Consolo, and L.G. Spagnoli Correlation between increased serum and tissue l-carnitine levels and improved muscle symptoms in hemodialyzed patients Am J Clin Nutr 38 1983 523 531 (Pubitemid 13010197)
82. P. Nilsson-Ehle, G. Cederblad, B. Fagher, M. Monti, and H. Thysell Plasma lipoproteins, liver function and glucose metabolism in haemodialysis patients. Lack of effect of l-carnitine supplementation Scand J Clin Lab Invest 45 1985 179 184 (Pubitemid 15106630)
83. M. Donatelli, C. Terrizzi, G. Zumro, V. Russo, M. Bucalo, and A. Scarpinaro Effects of l-carnitine on chronic anemia and adenosine triphosphate concentration in hemodialyzed patients Curr Ther Res 41 1987 621 624
84. W.D. Labonia l-Carnitine effects on anemia in hemodialyzed patients treated with erythropoietin Am J Kidney Dis 26 1995 757 764
85. M. Boran, I. Dalva, F. Gonenc, and S. Cetin Response to recombinant human erythropoietin [r-Hu EPO] and l-carnitine combination in patients with anemia of end-stage renal disease Nephron 73 1996 314 315 (Pubitemid 26159355)
86. D. Kavadias, C. Fourtounas, J. Tsouchhnikas, and K. Barboutis l-Carnitine and erythropoietin requirements in hemodialysis patients Am J Kidney Dis 28 1996 156 (Pubitemid 26231482)
87. G. Trovato, E. Iannetti, A. Murgo, G. Carpinteri, and D. Catalano Body composition and long-term levo-carnitine supplementation Clin Ter 149 1998 209 214 (Pubitemid 28495762)
88. U. Caruso, L. Leone, E. Cravotto, and D. Nava Effects of l-carnitine on anemia in aged hemodialysis patients treated with recombinant human erythropoietin: a pilot study Dial Transplant 27 1998 498 506 (Pubitemid 28387401)
89. Y. Matsumoto, I. Amano, S. Hirose, Y. Tsuruta, S. Hara, and M. Murata Effects of l-carnitine supplementation on renal anemia in poor responders to erythropoietin Blood Purif 19 2001 24 32
90. E. Vesela, J. Racek, L. Trefil, V. Jankovy'ch, and M. Pojer Effect of l-carnitine supplementation in hemodialysis patients Nephron 88 2001 218 223 (Pubitemid 32623484)
91. E. Vaux, D. Taylor, P. Altmann, B. Rajagopalan, K. Graham, and R. Cooper Effects of carnitine supplementation on muscle metabolism by the use of magnetic resonance spectroscopy and near-infrared spectroscopy in end-stage renal disease Nephron Clin Pract 97 2004 c41 c48
92. A.K. Kadiroglu, M.E. Yilmaz, D. Sit, I.H. Kara, and B. Isikoglu The evaluation of postdialysis l-carnitine administration and its effect on weekly requiring doses of rHuEPO in hemodialysis patients Renal Fail 27 2005 367 372 (Pubitemid 40993683)
93. A.H. Mitwalli, J.S. Al-Wakeel, A. Alam, N. Tarif, H. Abu-Aisha, and M. Rashed l-Carnitine supplementation in hemodialysis patients Saudi J Kidney Dis Transplant 16 2005 17 22 (Pubitemid 40367212)
94. G.J. Handelman Debate forum: carnitine supplements have not been demonstrated as effective in patients on long-term dialysis therapy Blood Purif 24 2006 140 142
95. B.D. Schreiber Debate forum: levocarnitine therapy is rational and justified in selected dialysis patients Blood Purif 24 2006 128 139 (Pubitemid 41820834)
96. C. Rebouche Carnitine function and requirements during the life cycle FASEB J 6 1992 3379 3386 (Pubitemid 23007103)
97. G. Guarnieri, R. Situlin, and G. Biolo Carnitine metabolism in uremia Am J Kidney Dis 38 Suppl 1 2001 S63 S67
98. N. Longo, C. Amat di San Filippo, and M. Pasquali Disorders of carnitine transport and the carnitine cycle Am J Med Genet C Semin Med Genet 142C 2006 77 85
99. S.C. Winter Treatment of carnitine deficiency J Inherit Metab Dis 26 2003 171 180 (Pubitemid 36889740)
100. A. De Vecchi, C. Patrosso, C. Novembrino, S. Finazzi, P. Colucci, and M. De Franceschi Folate supplementation in peritoneal dialysis patients with normal erythrocyte folate. Effect on plasma homocysteine Nephron 89 2001 297 302 (Pubitemid 34701762)
101. A. Arduini, M. Bonomini, V. Savica, A. Amato, and V. Zammit Carnitine in metabolic disease: potential for pharmacological intervention Pharmacol Ther 120 2008 149 156
102. E.P. Brass, S. Adler, K.E. Sietsema, W.R. Hiatt, A.M. Orlando, and A. Amato Intravenous l-carnitine increases plasma carnitine, reduces fatigue, and may preserve exercise capacity in hemodialysis patients Am J Kidney Dis 37 2001 1018 1028 (Pubitemid 32436575)